Prelude Therapeutics Incorporated · NASDAQ:PRLD
Prelude Therapeutics Incorporated shareholders
As of Jun 30, 2026, 72 institutions reported holding Prelude Therapeutics Incorporated, 62.2% of its shares. Largest: Orbimed Advisors LLC, Baker Bros. Advisors LP and Ra Capital Management, L.P. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Prelude Therapeutics Incorporated | Change | Filed |
|---|---|---|---|---|
| Orbimed Advisors LLC | 13.7M | 17.2% | +2.82M | Aug 14, 2026 |
| Baker Bros. Advisors LP | 10.1M | 12.7% | no change | Aug 14, 2026 |
| Ra Capital Management, L.P. | 6.48M | 8.1% | new | Aug 14, 2026 |
| Soleus Capital Management, L.P. | 3.38M | 4.2% | new | Aug 11, 2026 |
| Vanguard | 2.5M | 3.1% | +1.11M | Aug 13, 2026 |
| Kynam Capital Management, LP | 2.42M | 3.0% | +823K | Aug 14, 2026 |
| BlackRock | 1.8M | 2.3% | +1.48M | Aug 7, 2026 |
| Sphera Funds Management LTD. | 1.02M | 1.3% | +461K | Aug 14, 2026 |
| Two Sigma | 993K | 1.2% | +69,743 | Aug 14, 2026 |
| ADAR1 Capital Management, LLC | 901K | 1.1% | +748K | Aug 14, 2026 |